Results 71 to 80 of about 24,903 (156)

Stereochemical and Structural Characterization of Methionine Oxidation in the IgG1 Fc Region by Integrated NMR and LC-MS Analysis. [PDF]

Anal Chem
Yagi-Utsumi M, Yanaka S, Hashii N, Tomita K, Misawa T, Demizu Y, Ishii-Watabe A, Kato K.   +7 more
europepmc   +1 more source

Immunoglobulin G N-glycosylation remodeling in viral infections: immunomodulatory roles and potential biomarker implications. [PDF]

Front Immunol
Yan R, Wang C, Zhao X, Wang Y, Liu M, Shi X, Chen H, Li D.   +7 more
europepmc   +1 more source

[Characteristics of cellular receptors for immunoglobulin fragments Fc].

Postepy higieny i medycyny doswiadczalnej, 1988
openaire   +1 more source

VSIG4 suppresses antitumor T cell immunity via the SLC3A2-dependent metabolic-ionic checkpoint. [PDF]

J Immunother Cancer
Huang G, He R, Wang W, Wang H, Li Y, Zeng B, Shu P, Pan T, Yi M, Feng L, Cui Z, Li X, Du Y, Jiang H, Xiao X, Wang Y, Wang C.   +16 more
europepmc   +1 more source

Hybrid Supercharged Antibodies: A Rational Approach to Boost Immunoassay Sensitivity via Controlled Nanoparticle Adsorption. [PDF]

Langmuir
Sato J, Kasahara K, Nagatoishi S, Murakami K, Kuroda D, Caaveiro JMM, Nagai H, Tsumoto K.   +7 more
europepmc   +1 more source

Selective fluorination of Fc glycans enhances antibody-mediated effector functions. [PDF]

Proc Natl Acad Sci U S A
Wang X, Gomozkova M, Li S, Banerjee B, Zong G, Missiakas D, Wang LX.   +6 more
europepmc   +1 more source

First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults. [PDF]

J Clin Immunol
Lederman S, Daugherty BL, Herje N, Sullivan GM.   +3 more
europepmc   +1 more source

A Prototype timsOmni Platform Enables Confident Annotation of the Key Hypervariable CDR3 Regions of IgG Immunoglobulins Using Low- and High-Energy Electron-Based Fragmentation. [PDF]

Anal Chem
Ollivier S, Schuster D, van Rijswijck DMH, Stroganova I, Smyrnakis A, Fiala J, Kosmopoulou M, Suckau D, Pengelley S, Raether O, Greisch JF, Papanastasiou D, Heck AJR.   +12 more
europepmc   +1 more source

Different Fc scaffolds enhance the breadth of <i>in vitro</i> neutralization of the same Fab against different Rotavirus strains. [PDF]

Front Immunol
Miranda-Echagüe MR, Vezzani G, Morandi E, Della Peruta M, Scordio M, Reyes TAC, Oldrini D, Iturriza-Gómara M, Loomis RJ, Rossi O.   +9 more
europepmc   +1 more source